| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 1,486 | 1,897 | 1,538 | | Cost of Revenue | 1,081 | 1,356 | 485 | | | Gross Profit | 405 | 541 | 1,052 | | | Operating Expenses | | Research Development |
-
| 4 | 299 | | Selling General and Administrative | 1,113 | 1,180 | 4,372 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (707) | (643) | (3,618) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (10,617) | 88 | (378) | | Earnings Before Interest And Taxes | (8,899) | (2,894) | (5,065) | | Interest Expense |
-
|
-
| 3,101 | | Income Before Tax | (8,899) | (2,894) | (8,166) | | Income Tax Expense | (2,425) |
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (8,899) | (2,894) | (8,166) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (8,899) | (2,894) | (8,166) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($8,899) | ($2,894) | ($8,166) |
|
0.28% Nasdaq 0.00%
Income Statement
